Case number 1:17-cv-01832
CyDex Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 1 | Complaint (15) |
| Nov 6, 2019 | 116 | SO ORDERED (4) Docket Text: SO ORDERED, re [115] CONSENT JUDGMENT AND DISMISSAL ORDER, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 11/5/19. (ntl) |
| Nov 4, 2019 | 115 | Proposed Order (4) Docket Text: PROPOSED ORDER Consent Judgment and Dismissal Order by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Oct 25, 2019 | 114 | Status Report (1) Docket Text: Joint STATUS REPORT regarding Stipulation and Order to Stay by Actavis LLC, Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| Sep 12, 2019 | N/A | SO ORDERED (0) |
| Sep 10, 2019 | 113 | Stipulation (2) Docket Text: STIPULATION to Stay by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Sep 4, 2019 | 112 | Transcript (34) Docket Text: Official Transcript of Telephone Conference held on August 14, 2019 before Judge Jennifer L. Hall. Court Reporter Gail Verbano, Telephone number (302) 373-9428. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/25/2019. Redacted Transcript Deadline set for 10/7/2019. Release of Transcript Restriction set for 12/3/2019. (bpg) |
| Sep 3, 2019 | 111 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Response to Plaintiff's Supplemental Claim Charts on Infringement Pursuant to Paragraph 4(c) of the Default Standard for Discovery filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Aug 30, 2019 | 110 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Final Plaintiff's Response to Defendants' Invalidity Contentions filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Aug 19, 2019 | 108 | Redacted Document (3) Docket Text: REDACTED VERSION of [101] Letter to The Honorable Jennifer L. Hall from Jeremy A. Tigan regarding Response to Teva's August 6, 2019 Letter Regarding Discovery Disputes by CyDex Pharmaceuticals, Inc.. (Lyons, Jeffrey) |
| Aug 19, 2019 | 109 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Final Invalidity Contentions filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Aug 16, 2019 | N/A | Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #101. (ceg) |
| Aug 16, 2019 | 107 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Supplemental Claim Charts on Infringement by Teva Pharmaceuticals, USA and Actavis, LLC Pursuant to Paragraph 4(c) of the Default Standard for Discovery filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Aug 15, 2019 | N/A | SO ORDERED (0) |
| Aug 15, 2019 | N/A | Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the parties' letters regarding discovery disputes (D.I. [100], D.I. [101]), and having heard argument on August 14, 2019, IT IS HEREBY ORDERED that: (1) With regard to Defendant's request to compel Plaintiff to produce documents responsive to Defendant's Requests for Production Nos. 46-47, the Court GRANTS the request. The requested documents are relevant to Defendant's defense under 35 U.S.C. ยง 102(b) and Plaintiff has failed to demonstrate that producing the documents would be unreasonably burdensome or disproportionate to the needs of the case, particularly given that Plaintiff has not yet attempted to locate the relevant documents or determine the number of responsive documents. (2) With regard to Defendant's request to compel Plaintiff to produce the twelve clawed-back documents identified in Exhibit C to Defendant's letter (D.I. [100]), the Court GRANTS the request. Having reviewed the parties' submissions, and having conducted an in camera review of the documents, the record before the Court does not demonstrate that the documents are protected under the attorney-client privilege or work product doctrine. In particular, the record does not demonstrate that the documents were prepared either at the direction of counsel or for the purpose of obtaining legal advice. Defendant may redact the sentence on Document 6 beginning with the words "I've discussed." Ordered by Judge Jennifer L. Hall on 8/15/2019. (ceg) |
| Aug 14, 2019 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 8/14/2019. (*Court Reporter Gail Verbano.) (ceg) |
| Aug 14, 2019 | 104 | Redacted Document (10) Docket Text: REDACTED VERSION of [100] Letter by Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| Aug 14, 2019 | 105 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for Supplementation of Responses to Infringement Contentions and Responses to Invalidity Contentions to August 30, 2019 - filed by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Aug 13, 2019 | 103 | Letter (1) Docket Text: Letter to The Honorable Jennifer L. Hall from Jeremy A. Tigan regarding Documents for In Camera Review - re [102] Oral Order,,. (Tigan, Jeremy) |
| Aug 12, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court has reviewed Plaintiff's Letter dated August 9, 2019 (D.I. [101]), including its offer to submit the twelve documents at issue in the parties' discovery dispute to the Court for in camera review. Plaintiff shall submit for in camera review hard copies of the twelve documents no later than 1:00 P.M. on August 13, 2019. The documents should be delivered to the Clerk's office in an envelope addressed to U.S. Magistrate Judge Jennifer L. Hall and marked "CONFIDENTIAL/SUBMITTED FOR IN CAMERA REVIEW." Ordered by Judge Jennifer L. Hall on 8/12/2019. (ceg) |
| Aug 2, 2019 | 99 | Redacted Document (4) Docket Text: REDACTED VERSION of [96] Stipulation and Order re depositions by Actavis LLC, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| Aug 1, 2019 | N/A | SO ORDERED (0) |
| Jul 29, 2019 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the parties' Joint Motion for Teleconference to Resolve Discovery Disputes (D.I. [95].) A discovery dispute teleconference is set for August 14, 2019 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than August 6, 2019 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than August 9, 2019, any party opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party(ies) reasons for its opposition. Two courtesy copies of the letters are to be hand delivered to the Clerks' Office within one hour of e-filing. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 7/29/2019. (ceg) |
| Jul 25, 2019 | 95 | Motion for Miscellaneous Relief (2) Docket Text: Joint MOTION for Teleconference to Resolve Discovery Disputes - filed by Actavis LLC, Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| Jul 23, 2019 | 93 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiff's First Set of Requests for Admission (Nos. 1-228) and Defendants' Responses and Objections to Plaintiff's Second Set of Interrogatories (Nos. 10-21) filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Fry, David) |
| Jul 23, 2019 | N/A | Oral Order (0) |
| Jul 19, 2019 | N/A | Order (0) |
| Jul 19, 2019 | 89 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Robert Surina on August 2nd, 2019 filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jul 19, 2019 | 90 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Rodica Mazareanu on August 1st, 2019 filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jul 19, 2019 | 91 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Stefan Karlsson on July 30th, 2019 filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jul 19, 2019 | 92 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jim Mahanna on July 31th, 2019 filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jul 18, 2019 | 87 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Notice of Deposition Testimony of Diane Thompson, Gerold Mosher, Susan Gardner, Stephen Machatha, and Rupert Zimmermer filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jul 16, 2019 | 85 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Supplemental Responses to Defendants' Requests for Admissions (Nos. 6, 11-16, 60-62, 66) and (2) Supplemental Responses and Objections of CyDex Pharmaceuticals, Inc. to Defendants' Notice of Deposition of CyDex Pharmaceuticals, Inc. filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jul 16, 2019 | 86 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff CyDex Pharmaceuticals, Inc.'s Supplemental Responses and Answers to Defendants Teva Pharmaceuticals, USA, Inc. and Actavis, LLC's Second Set of Interrogatories (Nos. 8-10) filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jul 3, 2019 | 82 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding scheduling of discovery conference. (Keller, Karen) |
| Jul 3, 2019 | 83 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Response to Defendants' Fourth Set of Requests for Admissions (Nos. 60-69) and (2) Plaintiff's Response to Defendants' Fifth Set of Interrogatories (No. 25) filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jul 2, 2019 | 81 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Responses and Objections of CyDex Pharmaceuticals, Inc. to Defendants' Notice of Deposition of CyDex Pharmaceuticals, Inc. filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jul 1, 2019 | 80 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Lina Lohoz on July 30, 2019 filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jun 25, 2019 | 79 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's Notice of 30(b)(6) Deposition to Defendants filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jun 21, 2019 | 78 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff CyDex Pharmaceuticals, Inc.'s First Set of Requests for Admissions (Nos. 1-228) to Defendants and (2) Plaintiff CyDex Pharmaceuticals, Inc.'s Second Set of Interrogatories (Nos. 10-21) filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jun 14, 2019 | 77 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Response to Defendants' Third Set of Requests for Admissions (Nos. 21-59); and (2) Plaintiff's Response to Defendants' Fourth Set of Interrogatories (Nos. 12-24) filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jun 13, 2019 | 76 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Cydex Pharmaceuticals, Inc.'s Responses to Defendants' Third Requests for Production of Documents and Things (Nos. 46 & 47) filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jun 12, 2019 | 75 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants First Supplemental Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-9) filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jun 7, 2019 | 74 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Fifth Set of Interrogatories to Plaintiff (No. 25) (2) Defendants' Fourth Set of Requests for Admissions to Plaintiff (Nos. 60-69) filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jun 4, 2019 | N/A | SO ORDERED (0) |
| May 31, 2019 | 72 | Redacted Document (10) Docket Text: REDACTED VERSION of [70] Notice to Take Deposition of Teva Pharmaceuticals, USA Inc. by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| May 31, 2019 | 73 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants Notice of Deposition of Dr. Vincent Antle 2) Defendants Notice of Deposition of Dr. James Pipkin 3) Defendants Notice of Deposition of Ms. Michelle Baragary 4) Defendants Notice of Deposition of Matthew Foehr 5) Defendants Notice of Deposition of CyDex Pharmaceuticals, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) [Confidential] filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| May 29, 2019 | 71 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Certain Deadlines to Various Dates (See Stipulation) - filed by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| May 17, 2019 | 64 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Third Requests for Production of Documents and Things (Nos. 46 & 47) to Plaintiff filed by Teva Pharmaceuticals USA, Inc..(Fry, David) |
| May 17, 2019 | 65 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Cornelia Stancu on May 28, 2019 filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| May 17, 2019 | 66 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Mirabela Barbulescu on May 30, 2019 filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| May 17, 2019 | 67 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Maria Rotaru on June 4, 2019 filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| May 17, 2019 | 68 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Lorena Muggetti on May 29, 2019 filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| May 17, 2019 | 69 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Carmen Dragomir on June 6, 2019 filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| May 16, 2019 | 63 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Fourth Set of Interrogatories to Plaintiff (Nos. 12-24) (2) Defendants' Third Set of Requests for Admissions to Plaintiff (Nos. 21-59) filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| May 13, 2019 | 62 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Response to Defendants' Third Set of Interrogatories (No. 11) (2) Plaintiff Cydex Pharmaceuticals, Inc.'s Supplemental Responses and Answers to Defendants Teva Pharmaceuticals, Usa, Inc. and Actavis, LLC's First Set of Interrogatories (Nos. 1-7) (3) Plaintiff's Response to Defendants' Second Set of Requests For Admissions (Nos. 11-20) (4) Plaintiff Cydex Pharmaceuticals, Inc.'s Supplemental Responses and Answers to Defendants Teva Pharmaceuticals, Usa, Inc. and Actavis, LLC's Second Set of Interrogatories (Nos. 8-10) filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| May 3, 2019 | 60 | Redacted Document (4) Docket Text: REDACTED VERSION of [56] Letter by Actavis LLC, Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| May 3, 2019 | 61 | Redacted Document (3) |
| May 3, 2019 | 61 | Exhibit 1-4 (8) |
| May 3, 2019 | 61 | Main Document (3) Docket Text: REDACTED VERSION of [55] Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding Discovery Dispute by CyDex Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 1-4)(Tigan, Jeremy) |
| May 1, 2019 | N/A | SO ORDERED (0) |
| Apr 30, 2019 | 59 | Status Report (3) Docket Text: Interim STATUS REPORT by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Apr 28, 2019 | N/A | Order Cancelling Deadline (0) Docket Text: ORAL ORDER: Having reviewed the parties' submissions (D.I. 55, 56), IT IS HEREBY ORDERED that CyDex's request that the Court order Teva to supplement its response to infringement contentions is DENIED. The Court is not persuaded that Tevas response is "wholly inadequate" or otherwise inconsistent with Teva's obligations under paragraph 1(d) of the scheduling order. Instead, as Teva notes, its response reduces the infringement disputes to nine issues, notwithstanding CyDex's assertion of 126 patent claims. Moreover, the Court has no basis to reject Teva's representation that its response "accurately reflects Teva's current positions on the issue of infringement in this case and the positions it currently intends to take in expert discovery and at trial based on the record developed in the case so far." However, Teva should understand that if it does not disclose any substantive, factual bases for non-infringement (other than claiming CyDex cannot meet its burden), Teva will not be permitted to add new bases for non-infringement during expert discovery. IT IS FURTHER ORDERED that the teleconference scheduled for tomorrow is CANCELLED. ORDERED by Judge Leonard P. Stark on 4/28/19. (ntl) |
| Apr 26, 2019 | 57 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit an interim status report pursuant to the Scheduling Order to April 30, 2019 - filed by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Apr 18, 2019 | N/A | Order Setting Teleconference (0) |
| Apr 15, 2019 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants' Second Set of Requests for Admissions to Plaintiff (Nos. 11-20) and 2) Defendants' Third Set of Interrogatories to Plaintiff (No. 11) filed by Teva Pharmaceuticals USA, Inc..(Fry, David) |
| Mar 22, 2019 | 52 | Letter (2) Docket Text: Joint Letter to the Honorable Leonard P. Stark from Jeremy A. Tigan regarding Scheduling of Discovery Teleconference. (Tigan, Jeremy) |
| Feb 25, 2019 | 51 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Cydex Pharmaceuticals, Inc.'s Answers to Defendants Teva Pharmaceuticals, USA, Inc. and Actavis, LLC's Second Set of Interrogatories (Nos. 8-10), (2) Plaintiff Cydex Pharmaceuticals, Inc.'s Responses to Defendants Teva Pharmaceuticals, USA, Inc. and Actavis, LLC's Second Set of Requests for Production of Documents and Things (Nos. 32-45), and (3) Plaintiff Cydex Pharmaceuticals, Inc.'s Responses to Defendants Teva Pharmaceuticals, USA, Inc. and Actavis, LLC's First Set of Requests for Admissions (Nos. 1-10) filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Feb 22, 2019 | N/A | Order Cancelling Deadline (0) |
| Feb 15, 2019 | 49 | Letter (2) Docket Text: Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding Claim Construction. (Tigan, Jeremy) |
| Feb 13, 2019 | N/A | Order Cancelling Deadline (0) |
| Feb 8, 2019 | 47 | Letter (3) Docket Text: Letter to The Honorable Leonard P. Stark from David M. Fry regarding Discovery Dispute - re [46] Letter. (Fry, David) |
| Feb 6, 2019 | 46 | Letter (3) |
| Feb 6, 2019 | 46 | Exhibit 1-3 (12) |
| Feb 6, 2019 | 46 | Main Document (3) Docket Text: Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding Discovery Dispute. (Attachments: # (1) Exhibit 1-3)(Tigan, Jeremy) |
| Feb 4, 2019 | N/A | Order Setting Teleconference (0) |
| Jan 28, 2019 | 43 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants' First Set of Requests for Admissions to Plaintiff (Nos. 1-10); 2) Defendants' Second Set of Interrogatories to Plaintiff (Nos. 8-10); and 3) Defendants' Second Set of Requests for Production of Documents and Things (Nos. 32-45) to Plaintiff) filed by Teva Pharmaceuticals USA, Inc..(Fry, David) |
| Jan 28, 2019 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants' Notice of Subpoena for the Production of Documents to Bristol Myers Squibb Co. and 2) Defendants' Notice of Subpoena for the Production of Documents to Hovione LLC filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 22, 2019 | 41 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Response to Defendants' Invalidity Contentions filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jan 22, 2019 | 42 | Letter (2) Docket Text: Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding request for the scheduling of a discovery teleconference. (Tigan, Jeremy) |
| Jan 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alison M. Heydorn for Actavis LLC and Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Jan 8, 2019 | N/A | SO ORDERED (0) |
| Jan 4, 2019 | 40 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alison Heydorn - filed by Actavis LLC, Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| Dec 26, 2018 | 39 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants' Response to Plaintiff's Paragraph 4(c) Initial Infringement Contentions; and 2) Defendants' Initial Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Nov 30, 2018 | 38 | SO ORDERED (2) Docket Text: SO ORDERED, re Stipulation to Amend Scheduling Order -- Claim Construction Answering Brief due by 4/12/2019. Claim Construction Opening Brief due by 3/15/2019. A Markman Hearing is set for 5/28/2019 at 09:00 AM in Courtroom 6B. Signed by Judge Leonard P. Stark on 11/30/18. (ntl) |
| Nov 28, 2018 | 37 | Letter (1) |
| Nov 28, 2018 | 37 | Stipulation to Amend Schedule (2) |
| Nov 28, 2018 | 37 | Main Document (1) Docket Text: Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding Stipulation to Amend Scheduling Order - re [24] Scheduling Order,,. (Attachments: # (1) Stipulation to Amend Schedule)(Tigan, Jeremy) |
| Oct 22, 2018 | 36 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Claim Charts on Infringement by Teva Pharmaceuticals, USA and Actavis, LLC Pursuant to Paragraph 4(c) of the Default Standard for Discovery filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Sep 4, 2018 | N/A | SO ORDERED (0) |
| Aug 30, 2018 | N/A | SO ORDERED (0) |
| Aug 29, 2018 | 35 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Reisman, Benjamin A. Katzenellenbogen, Ali S. Razai, Karen M. Cassidy and Kimberly A. Kennedy - filed by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Aug 24, 2018 | 31 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Samuel S. Park as co-counsel.. (Fry, David) |
| Aug 24, 2018 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Fry, David) |
| Aug 24, 2018 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosure Pursuant to Paragraph 3 of the Default Standard for Discovery filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Aug 24, 2018 | 34 | Proposed Order (29) Docket Text: PROPOSED ORDER --Stipulated Protective Order-- by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Aug 20, 2018 | N/A | SO ORDERED (0) |
| Aug 20, 2018 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Paragraph 4(a) Disclosures Identifying the Asserted Patents and Accused Products filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Aug 17, 2018 | 29 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to submit proposed protective order to August 24, 2018 - filed by Actavis LLC, Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| Aug 8, 2018 | N/A | SO ORDERED (0) |
| Aug 3, 2018 | 28 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to August 17, 2018 - filed by Actavis LLC, Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| Aug 2, 2018 | N/A | SO ORDERED (0) |
| Jul 30, 2018 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants' Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-9); and 2) Defendants' Objections and Responses to Plaintiff's First Set of Requests for Production (Nos. 1-59) filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Fry, David) |
| Jul 27, 2018 | 25 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Parties to File a Proposed Protective Order to August 3, 2018 - filed by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Jul 27, 2018 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiff CyDex Pharmaceuticals, Inc.'s Answers to Defendants Teva Pharmaceuticals, USA, Inc. and Actavis, LLC's First Set of Interrogatories (Nos. 1-7); (2) Plaintiff CyDex Pharmaceuticals, Inc.'s Responses to Defendants Teva Pharmaceuticals, USA, Inc. and Actavis, LLC's First Set of Requests for Production of Documents and Things (Nos. 1-31); (3) Plaintiff's Initial Disclosures Pursuant to Rule 26(a)(1); and (4) Plaintiff's Initial Disclosure Pursuant to Paragraph 3 of the Default Standard for Discovery filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jul 24, 2018 | 24 | Scheduling Order (15) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 6/14/2019. Status Report due by 4/26/2019. Claim Construction Opening Brief due by 1/25/2019. Claim Construction Answering Brief due by 2/22/2019. A Markman Hearing is set for 4/1/2019 at 01:00 PM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 1/3/2020. A Final Pretrial Conference is set for 1/10/2020 at 01:30 PM in Courtroom 6B before Judge Leonard P. Stark. A 5-6 day Bench Trial is set for 1/27/2020 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 7/20/18. (ntl) |
| Jul 18, 2018 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva Pharmaceuticals USA, Inc. And Actavis, LLC's Initial Disclosures Pursuant to Rule 26(a)(1) filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jul 13, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jul 11, 2018 | N/A | SO ORDERED (0) |
| Jul 10, 2018 | 21 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ryan B. Hauer - filed by Actavis LLC, Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Jul 10, 2018 | 22 | Proposed Order (15) |
| Jul 10, 2018 | 22 | Cover Letter (1) |
| Jul 10, 2018 | 22 | Main Document (15) Docket Text: PROPOSED ORDER // Scheduling Order re [18] Order, by CyDex Pharmaceuticals, Inc.. (Attachments: # (1) Cover Letter)(Tigan, Jeremy) |
| Jun 29, 2018 | 20 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Cydex Pharmaceuticals Inc.'s First Set of Interrogatories (Nos. 1-9); and (2) Cydex Pharmaceuticals Inc.'s First Set of Request for Production (Nos. 1-59) filed by CyDex Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Jun 27, 2018 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' First Set of Interrogatories to Plaintiff (Nos. 1-7) (2) Defendants' Requests for Production of Documents and Things (Nos. 1-31) to Plaintiff filed by Actavis LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jun 26, 2018 | N/A | Order (0) |
| Apr 18, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 16, 2018 | N/A | SO ORDERED (0) |
| Apr 12, 2018 | 17 | Answer to Counterclaim (11) Docket Text: ANSWER to [14] Answer to Complaint, Counterclaim by CyDex Pharmaceuticals, Inc..(Blumenfeld, Jack) |
| Apr 11, 2018 | 16 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Claire A. Fundakowski, Eimeric Reig-Plessis, George C. Lombardi, Samuel S. Park, and Kevin E. Warner - filed by Actavis LLC, Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Apr 9, 2018 | N/A | SO ORDERED (0) |
| Apr 5, 2018 | 15 | Stipulation (4) Docket Text: STIPULATION DISMISSING DEFENDANT TEVA PHARMACEUTICAL INDUSTRIES LTD. AND AMENDMENT OF CAPTION by Actavis LLC, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Mar 22, 2018 | 13 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceuticals USA, Inc. for Actavis LLC; Corporate Parent Teva Pharmaceutical Industries Ltd for Teva Pharmaceuticals USA, Inc. filed by Actavis LLC, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Mar 22, 2018 | 14 | Answer to Complaint (23) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against CyDex Pharmaceuticals, Inc. by Actavis LLC, Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd..(Keller, Karen) |
| Jan 2, 2018 | N/A | SO ORDERED (0) |
| Dec 28, 2017 | 6 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Teva Pharmaceutical USA, Inc. on 12/22/2017 by CyDex Pharmaceuticals, Inc.. Waiver of Service due by 1/22/2018. (Tigan, Jeremy) |
| Dec 28, 2017 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by CyDex Pharmaceuticals, Inc.: For Teva Pharmaceuticals USA, Inc. waiver sent on 12/22/2017, answer due 2/20/2018. (Tigan, Jeremy) |
| Dec 28, 2017 | 8 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Teva Pharmaceutical Industries Ltd. on 12/22/2017 by CyDex Pharmaceuticals, Inc.. Waiver of Service due by 1/22/2018. (Tigan, Jeremy) |
| Dec 28, 2017 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by CyDex Pharmaceuticals, Inc.: For Teva Pharmaceutical Industries Ltd. waiver sent on 12/22/2017, answer due 3/22/2018. (Tigan, Jeremy) |
| Dec 28, 2017 | 10 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Actavis, LLC on 12/22/2017 by CyDex Pharmaceuticals, Inc.. Waiver of Service due by 1/22/2018. (Tigan, Jeremy) |
| Dec 28, 2017 | 11 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by CyDex Pharmaceuticals, Inc.: For Actavis LLC waiver sent on 12/22/2017, answer due 2/20/2018. (Tigan, Jeremy) |
| Dec 28, 2017 | 12 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Teva Pharmaceuticals USA, Inc. and Actavis, LLC to move, answer, or otherwise respond to the Complaint to March 22, 2018 - filed by CyDex Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Dec 27, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Dec 21, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Actavis LLC on 12/21/2017; Teva Pharmaceutical Industries Ltd. on 12/21/2017; Teva Pharmaceuticals USA, Inc. on 12/21/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Dec 20, 2017 | 1 | Exhibits A-E (202) |
| Dec 20, 2017 | 1 | Civil Cover Sheet (1) |
| Dec 20, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Dec 20, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/9/2017. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 5/9/2020. (ceg) |
| Dec 20, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,410,077 B2; 9,200,088 B2; 9,493,582 B2. (ceg) |
| Dec 20, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ligand Pharmaceuticals, Inc. for CyDex Pharmaceuticals, Inc. filed by CyDex Pharmaceuticals, Inc. (ceg) |
| Dec 20, 2017 | 1 | Main Document (15) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Actavis LLC, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2288999.) - filed by CyDex Pharmaceuticals, Inc. (Attachments: # (1) Exhibits A-E, # (2) Civil Cover Sheet)(ceg) |
| Dec 20, 2017 | 1 | Complaint* (1) |
